+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2013-10-10Number of Pages: 97

Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

The report on the global transcriptomics technologies market bundles all factors that have influenced this market over the past few years and utilizes clear and effective processes and methodologies to ascertain the future of the global transcriptomics technologies market. The report states that the global transcriptomics technologies market is expected to expand handsomely over the next few years.

The global transcriptomics technologies market is divided in terms of technology, applications, and geography. The report then quantifies the leading segments according to each criterion in order to simplify the evaluation process of the global transcriptomics technologies market. This involves defining all market drivers and restraints that propel and hinder the global transcriptomics technologies market, respectively.

The key driving factor of the global transcriptomics technologies market is the growing requirement for all products in the market for personalized healthcare and comparison diagnostics. Other driving factors for the global transcriptomics technologies market include the availability of sufficient gear in laboratories as well as healthcare organizations, along with an increasing awareness of the benefits that transcriptomics technologies can bring to the healthcare sector.

The report explains key aspects that could affect the global transcriptomics technologies market in the coming few years.

The report utilizes proven research methods such as SWOT analysis and Porter’s five forces analysis to update the report’s user with the global transcriptomics technologies market’s determinant macro and micro factors as well as the value chain.

Overview of the Global Transcriptomics Technologies Market 

The global transcriptomics technologies market is exhibiting a 15.90% CAGR from 2013 to 2019. The market was valued at US$1.65 bn in 2012. The consistent growth pattern of the market will lead to a value of US$4.6 bn for the global transcriptomics technologies market by the end of 2019.

The key segments of the global transcriptomics technologies market according to technology are gene regulation technologies, microarrays, PCR, and NGS. Transcriptomics technologies find major use in gene expression patterns and drug discovery. Transcriptomics technologies are also applied in the clinical diagnosis of central nervous system disorders, cardiovascular disorders, and cancers. Transcriptome analysis tools offer accurate insights into gene sequence identification, gene expression patterns, and gene regulation mechanisms.

The global transcriptomics technologies market could be restrained by factors such as the non-availability of resources and tools that help in analyzing critical and complex data, the lack of tools that allow for biology computation, and the overall lack of skilled manpower with domain expertise.

The global transcriptomics technologies market is led by Asia Pacific, which has the fastest growth rate, due to the sharply increasing population in the region, coupled with the consequent boost in supply by the vendor base in the region. North America is the largest regional segment of the global transcriptomics technologies market and held a revenue share of 35.0% in 2012.

Companies mentioned in the research report 
 

The top players in the global transcriptomics technologies market are Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., and Life Technologies Corporation. 

Key segments of the Global Transcriptomics Technologies Market

Transcriptomics Technologies Market, by Technology

  • Microarrays
  • Polymerase Chain Reaction (PCR)
  • Gene Regulation Technologies
  • Next Generation Sequencing (NGS)

Transcriptomics Technologies Market, by Applications

  • Clinical Diagnostics
  • Drug Discovery and Research
  • Bioinformatics
  • Comparative Transcriptomics Studies

Major regions analyzed under this research report are: 

  • Europe
  • North America 
  • Asia Pacific 
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Content

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

 

Chapter 3 Market Overview

3.1 Introduction

      3.1.1 Market Potential of Transcriptomics Technologies

      3.1.2 Future Scenario of Transcriptomics

      3.1.3 Market Dynamics

3.2 Market Drivers

      3.2.1 Technological Advancements

      3.2.2 Rising Preference for Personalized Medicine from both ends (Manufacturers and Consumers)

      3.2.3 Increasing Research and Development Investments

      3.2.4 Impact Analysis of Market Drivers

3.3 Market Restraints

      3.3.1 Lack Of Efficient Data Analysis Tools

      3.3.2 Impact Analysis of Market Restraints

3.4 Market Opportunities

      3.4.1 Focus on Development of Bioinformatics Tools and Services

3.5 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

      3.5.1 Bargaining Power Of Buyers

      3.5.2 Bargaining Power Of Suppliers

      3.5.3 Threat of Substitutes

      3.5.4 Threat of New Entrants

      3.5.5 Competitive Rivalry

3.6 Market Attractiveness Analysis: Global Transcritpomics Technologies Market, By Geography

 

Chapter 4 Global Transcriptomics Technologies Market, By Technology

4.1 Introduction

4.2 Microarrays

      4.2.1 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.2 Polymerase Chain Reaction (PCR)

               4.2.2.1 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.3 Gene Regulation Technologies (RNA Interference Technology)

              4.2.3.1 Global Gene Regulation Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

      4.2.4 Next Generation Sequencing (NGS)

              4.2.4.1 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 5 Global Transcriptomics Technologies Market, By Application

5.1 Overview

5.2 Clinical Diagnostics

      5.2.1 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.3 Drug Discovery And Research

      5.3.1 Global Drug Discovery and Research Market, Size and Forecast, 2011 - 2019 (USD Million)

5.4 Bioinformatics

      5.4.1 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

5.5 Comparative Transcriptome Studies

      5.5.1 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 6 Global Transcriptomics Technologies Market, By Geography

6.1 Overview

      6.1.1 Global Transcriptomics Technologies Market, By Geography, Size and Forecast, 2011 – 2019 (USD Million)

      6.1.2 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

6.2 North America

      6.2.1 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.3 Europe

      6.3.1 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

6.5 Rest of the World (Row)

      6.5.1 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

 

Chapter 7 Competitive Landscape

7.1 Market Share By Key Players: Global Transcriptomics Technologies Market, 2012 (%)

 

Chapter 8 Recommendations

8.1 Collaboration with Academic and Research Institutes

8.2 Focus on Imparting Education about Genomic Medicine

 

Chapter 9 Company Profiles

9.1 Affymetrix, Inc.

      9.1.1 Company Overview

      9.1.2 Financial Overview

      9.1.3 Product Portfolio

      9.1.4 Business Strategies

      9.1.5 Recent Developments

9.2 Agilent Technologies, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

      9.2.5 Recent Developments

9.3 Bio-Rad Laboratories, Inc.

      9.3.1 Business Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 Danaher Corporation

      9.4.1 Business Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 F. Hoffmann-La Roche Ltd.

      9.5.1 Company Overview      

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

      9.5.5 Recent Developments

9.6 Illumina, Inc.

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

      9.6.5 Recent Developments

9.7 Life Technologies Corporation

      9.7.1 Company Overview

      9.7.2 Financial Overview

      9.7.3 Product Portfolio

      9.7.4 Business Strategies

      9.7.5 Recent Developments

9.8 LC Sciences, LLC

      9.8.1 Company Overview

      9.8.2 Financial Overview

      9.8.3 Product Portfolio

      9.8.4 Business Strategies

      9.8.5 Recent Developments

9.9 Qiagen N.V.

      9.9.1 Company Overview

      9.9.2 Financial Overview

      9.9.3 Product Portfolio

      9.9.4 Business Strategies

      9.9.5 Recent Developments

9.10 Sigma-Aldrich Corporation

      9.10.1 Company Overview

      9.10.2 Financial Overview

      9.10.3 Product Portfolio

      9.10.4 Business Strategies

      9.10.5 Recent Developments

9.11 Thermo Fisher Scientific

      9.11.1 Company Overview

      9.11.2 Financial Overview

      9.11.3 Product Portfolio

      9.11.4 Business Strategies

      9.11.5 Recent Developments

List of Figures

 

FIG. 1 Central Dogma : Transcriptomics Technologies Market

FIG. 2 Transcriptomics Technologies: Market Segmentation

FIG. 3 Global Transcriptomics Technologies Market, By Technology, 2012 (USD Million)

FIG. 4 Porter’s Five Forces Analysis: Global Transcriptomics Technologies Market

FIG. 5 Market Attractiveness Analysis: Global Transcriptomics Technologies Market, By Geography

FIG. 6 Global Microarrays Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 7 Global PCR Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 8 Global Gene Regulation Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 9 Global Next Generation Sequencing Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 10 Global Clinical Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 11 Global Drug Discovery Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 12 Global Bioinformatics Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 13 Global Comparative Transcriptome Studies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 14 Comparative Analysis: Global Transcriptomics Technologies Market, By Geography, 2012 & 2019 (Value %)

FIG. 15 North America Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 16 Europe Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 17 Asia-Pacific Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 18 Row Transcriptomics Technologies Market, Size and Forecast, 2011 - 2019 (USD Million)

FIG. 19 Market Share Analysis: Global Transcriptomics Technologies Market, 2012 (%)

FIG. 20 Affymetrix, Inc., Annual Revenue:  2010 – 2012 (USD Million)

FIG. 21 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 22 Bio-Rad Laboratories, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 23 Danaher Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 24 F. Hoffmann-La Roche Ltd., Annual Revenue: 2010 – 2012 (USD Million) (1 CHF = 1.09 USD)

FIG. 25 Illumina, Inc., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 26 Life Technologies Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 27 Qiagen N.V., Annual Revenue: 2010 – 2012 (USD Million)

FIG. 28 Sigma Aldrich Corporation, Annual Revenue: 2010 – 2012 (USD Million)

FIG. 29 Thermo Fisher Scientific, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Transcriptomics Technologies Market

TABLE 3 Impact Analysis of Market Drivers

TABLE 4 Impact Analysis of Market Restraints

TABLE 5 Global Transcriptomics Technologies Market, By Technology, Size and Forecast, 2011-2019 (USD Million)

TABLE 6 Global Transcriptomics Technologies Market, By Application, Size and Forecast, 2011-2019 (USD Million)

TABLE 7 Global Transcriptomics Technologies Market, By Geography, Size and Forecast,     2011 – 2019(USD Million)

Transcriptomics is one of the flourishing “Omics” technologies (proteomics, genomics, metabolomics and others) across the globe. Transcriptomics research provides insights on structure and function of complete set of RNA molecules present in a given cell. Currently, the analysis of transcriptome of several organisms is facilitated with the help of advanced technological platforms such as next generation sequencing platforms followed by polymerase chain reaction, microarrays and gene regulation technologies. These technologies are applied in the process of drug discovery, medical research, clinical diagnosis of diseases and others. With the burgeoning demand for targeted therapeutics and continuous improvements in healthcare infrastructure, transcriptomics technologies promise lucrative commercialization prospects. Hence, transcriptomics research enables development of potential and novel therapeutics and diagnostics. 

 

Evolution of technological analysis platforms such as next generation sequencing technologies, microRNA technology, RNA interference technology and PCR technologies enable effective analysis of transcriptome of different organisms with greater precision and accuracy. Currently, there is a demand for technology sophistication to ensure optimum results. For example, presently, there is a need for multiplexed RNA sequencing and quantagene RT-PCR which enable the sequencing and analysis of numerous transcripts and reads simultaneously. These technological sophistications in turn create a demand for effective data analysis tools and service (bioinformatics) in order to handle and manage huge amount of data from these technological platforms.

 

Transcriptomics technologies are applied majorly in studying gene expression patterns, drug discovery and clinical diagnosis of disorders such as cardiovascular, central nervous system disorders, cancers and others. Transcriptome analysis tools and services are used in identification of novel gene sequences and potential drug targets. Also, they provide insights about gene expression patterns and gene regulation mechanisms that are responsible to trigger the functioning and production of proteins. There is a lot of complexity involved in study of structural and functional aspects of complete set of transcripts present in a given cell or population of cells. Henceforth, several pharmaceutical and biotechnology companies are investing in medical research to develop robust methodologies with high efficiency and reliability.

 

Geographically, North America dominated the global transcriptomics technologies market in 2012 with a revenue share of over 35%. Presence of well equipped medical and research laboratories, increased awareness of biotechnological research and increased participation of respective governments are some of the major factors responsible for region’s leadership position. Factors such as continuous improvisation in healthcare infrastructure, rigorous research and development initiatives followed by increased commercialization of research outcomes are expected to drive the growth of this market during the forecast period. In Asia-Pacific region ongoing development of technologies and infrastructure facilities along with increasing acceptance towards the novel approaches in biotechnology research will further enhance the uptake of transcriptomics technologies and drive market growth. On the other hand factors which might hamper the growth of overall transcriptomics market are lack of effective computational biology tools and services required for efficient analysis of complex data followed by lack of domain expertise.

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries